| Шығарылым |
Бөлім |
Атауы |
Файл |
| № 8 (2016) |
Articles |
COMBINATION OF VEMURAFENIB+KOBIMETINIB FUNDAMENTALLY CHANGES PROGNOSIS FOR METASTATIC MELANOMA |
|
| № 17 (2016) |
Articles |
ROLE OF NEW ANTIANGIOGENIC DRUGS IN THE SECOND-LINE TREATMENT OF NON-SMALL-CELL LUNG CANCER |
|
| № 7 (2018) |
Articles |
GONADOTROPIN-RELEASING HORMONE AGONISTS-INDUCED OVARIAN SUPPRESSION IN EARLY BREAST CANCER |
|
| Том 26, № 7 (2019) |
Articles |
PEComas: what are the treatment options? Literature review and personal experience |
|
| Том 26, № 12 (2019) |
Articles |
The predictive value of nutritional deficiency in the treatment of patients with locally advanced stomach cancer |
|
| Том 27, № 7 (2020) |
Articles |
Prospects for the use of immunotherapy in the treatment of head and neck squamous cell carcinoma |
|
| Том 27, № 7 (2020) |
Articles |
Comparison of systems for evaluating the effectiveness of modern immunotherapy |
|
| Том 27, № 7 (2020) |
Articles |
Evaluation of the effectiveness and the possibility of optimizing the methodology for analyzing the plasma microRNA-371-3 (HSA-miR-371-3p) level for the diagnosis and monitoring of the effect of therapy of germ cell tumors in men |
|
| Том 27, № 11 (2020) |
Articles |
Ten-year experience of pharmacotherapy for soft tissue sarcomas |
|
| Том 27, № 11 (2020) |
Articles |
The use of panitumumab in the treatment of chemoresistant metastatic sigmoid colon adenocarcinoma: a clinical case |
|
| Том 28, № 7 (2021) |
Articles |
Experience of using prolgolimab in real clinical practice |
|
| Том 28, № 7 (2021) |
Articles |
Assessment of the dynamics of immunological parameters at the beginning of therapy as prognostic and predictive factors in patients with melanoma |
|
| Том 29, № 7 (2022) |
Articles |
The use of pazopanib in the treatment of disseminated soft tissue sarcoma: personal experience |
|
